Neuroblastoma 1

Common Name(s)

Neuroblastoma 1

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroblastoma 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroblastoma 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Neuroblastoma 1" returned 158 free, full-text research articles on human participants. First 3 results:

Type-1 interferons contribute to oxygen glucose deprivation induced neuro-inflammation in BE(2)M17 human neuroblastoma cells.
 

Author(s): Myles Robert Minter, Moses Zhang, Robert Charles Ates, Juliet Marie Taylor, Peter John Crack

Journal:

 

Hypoxic-ischaemic injuries such as stroke and traumatic brain injury exhibit features of a distinct neuro-inflammatory response in the hours and days post-injury. Microglial activation, elevated pro-inflammatory cytokines and macrophage infiltration contribute to core tissue damage ...

Last Updated: 31 Mar 2014

Go To URL
HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib.
 

Author(s): Anna Lisa Furfaro, Sabrina Piras, Mario Passalacqua, Cinzia Domenicotti, Alessia Parodi, Daniela Fenoglio, Maria Adelaide Pronzato, Umberto Maria Marinari, Lorenzo Moretta, Nicola Traverso, Mariapaola Nitti

Journal: Biochim. Biophys. Acta. 2014 Apr;1842(4):613-22.

 

High-risk neuroblastoma (NB) is characterized by the development of chemoresistance, and bortezomib (BTZ), a selective inhibitor of proteasome, has been proposed in order to overcome drug resistance. Considering the involvement of the nuclear factor-erythroid-derived 2-like 2 (Nrf2) ...

Last Updated: 24 Feb 2014

Go To URL
XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway.
 

Author(s): Xiao-Hong Tian, Wei-Jian Hou, Yan Fang, Jun Fan, Hao Tong, Shu-Ling Bai, Qu Chen, He Xu, Yan Li

Journal:

 

Neuroblastoma (NB) is the most common extracranial solid tumor in childhood. The present treatment including surgery, chemotherapy and radiation, which have only 40% long-term cure rates, and usually cause tumor recurrence. Thus, looking for new effective and less toxic therapies ...

Last Updated: 19 Dec 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Neuroblastoma 1" returned 0 free, full-text review articles on human participants.

 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

High Risk Neuroblastoma Study 1 (1.5) of SIOP-Europe (SIOPEN)
 

Status: Recruiting

Condition Summary: Neuroblastoma

 

Last Updated: 10 Oct 2012

Go to URL

Last Updated: 28 Aug 2014

Go to URL
Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors
 

Status: Recruiting

Condition Summary: Recurrent or Refractory Solid Tumors; Ewing Sarcoma; Rhabdomyosarcoma; Neuroblastoma; Osteosarcoma

 

Last Updated: 21 Jan 2014

Go to URL